India, April 24 -- Aligos Therapeutics, Inc. (ALGS) has granted stock options to newly hired employees as part of inducement awards approved under Nasdaq Listing Rule 5635(c)(4), the company announced Friday.
The Compensation Committee granted non-qualified stock options to purchase 10,700 shares of common stock on April 22, 2026. The award were issued under Aligos' 2024 Inducement Plan, which is reserved exclusively for individuals who were not previously employed by the company. The options carry an exercise price per share equal to the closing price of Aligos' common stock on the grant date. Vesting will occur over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installm...